書籍詳細

総論

P.8 掲載の参考文献

• 1) Suda T, et al: Hematopoiesis and angiogenesis. Int J Hematol 71: 99, 2000
  pubmed

• 2) 須田年生: 実験医学バイオサイエンスシリーズ 7, 血液幹細胞の運命, 羊土社,東京, 1992

• 3) 金倉 譲: 造血幹細胞の性状. 日本内科学会雑誌 87: 1451-1456, 1998

P.19 掲載の参考文献

• 1) 仁保喜之: 貧血の診断と分類の進め方. 内科82: 423-426, 1998

• 2) 北村 聖: 診断のためのアプローチ. 日内会誌88: 969-974, 1999

• 3) 関川哲明, 山田 尚: 実地医家のための貧血の診察と検査. 臨床成人病9: 1147-1153, 2001

• 4) 別所正美: 血液疾患診療マニュアル〜二次性貧血. 日医会誌124: S148-S151, 2000

P.43 掲載の参考文献

• 1) Hansen J, Clift RA, Thomas ED, et al: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 303: 506-567, 1980

• 2) Morishima Y, Sasazuki T, Inoko H, et al: The clinical significance of human Ieukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HIA-B, and HLA-DR matched unrelated donors. Blood 99: 4200, 2002

• 3) Kodera Y, Morishima Y, Kato S, et al: Analysis of 500 bone marrow transplants from unrelated donors (OR-BMT) facilitated by the Japan Marrow Donor Program;comfirmation of OR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 24: 995-1003, 1999
  pubmed

• 4) Ringden O, Romberger M, Runde V, et al: Peripheral blood stem cell transplantation from unrelated donors;a comparison with marrow transplantation. Blood 94: 455-464, 1999

P.49 掲載の参考文献

• 1) Thomsa ED, Blume KG, Froman SJ: Hematopoietic cell transplantation, 2nd Ed, Blackwell Science, Malden, 1999

• 2) Korbling M, Dorken B, Ho AD, et al: Autologous transplantation of blood-derived hemopoiedc stem cells after myeloablative therapy in a patient with Burkittis lymphoma. Blood 67: 529-532, 1986

• 3) Gluckman E, Broxmeyer HA, Auerbach AD, et al: Hematopoietic reconstitution in a patient with Fanconi' s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321: 1174-1178, 1989

• 4) Kessinger A, Smith DM, Strandjord SE, et al: Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 4: 643-646, 1989

• 5) Ash RC, Casper JT, Chitambar CR, et al: Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J 322: 485-494, 1990

• 6) Slavin S, Nagler A, Naparstek E, et al: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91: 75663, 1996

• 7) Childs R, Chernoff A, Contentin N, et al: Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic pehpheral-blood stem-cell transplantation. N Engl J Med 343: 750-758, 2000
  pubmed

疾患編

P.153 掲載の参考文献

• 1) Ichimaru M, et al: Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-1976;relationship to radiation dose absorbed by the marrow. J Natl Cancer Inst 69: 323-328, 1982

• 2) Isomaki HA, et al: Excess risk of lymphomas, leukemias and myelomas in patients with rheumatoid arthritis. J Chronic Dis 31: 691-696, 1978
  pubmed

• 3) Durie BGM, Salmon SE: A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatrnent and survival. Cancer 36: 842-854, 1975

• 4) Mellstedt H, et al: Treatment of multiple myeloma with interferon alpha;the Scandinavian experience. Br J Haematol 79 (Suppl 1): 21-35, 1991

• 5) Mandelli F, et al: Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N Engl J Med 322: 1430-1434, 1990
  pubmed

• 6) Gahrton G, et al : Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 325: 1267-11273, 1991
  pubmed

• 7) 日本造血細胞移植学会: 平成12年度全国調査報告書, p117, 2000年12月

• 8) Barlogie B, et al: Superiority of tandem autologous transplantation over standard therapy of previously untrated multiple myeloma. Blood 89: 789-793, 1997

• 9) Slavin S, et al: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction fro the treatment of malignant and non-malignant hematologic diseases. Blood 91: 756-763, 1998

P.160 掲載の参考文献

• 1) 松尾辰樹: 慢性骨髄性白血病. エッセンシャル血液病学, 医歯薬出版株式会社, 東京, pp133-141, 1999.

• 2) 柴田 昭: 慢性骨髄性白血病. 血液病学, 文光堂, 東京, pp1030-1043, 1995.

• 3) 喜多嶋康一: 慢性骨髄性白血病とその急性転化の診断基準-病型分類. 内科65: 1393, 1990.

P.165 掲載の参考文献

• 1) 大野竜三: 赤血球増加症と骨髄線維症. NIM LECTURES 血液病学, 医学書院, 東京, pp154-164, 1996

• 2) 溝口秀昭: 赤血球増加症. 血液病学, pp769-778, 文光堂, 東京1995

• 3) Berlin NI, et al: Polycythemia, pp1-200, Grune and Stratton, New York, 1976

P.170 掲載の参考文献

• 1) 近藤春樹: 慢性特発性骨髄線維症. 日本臨牀20 (別冊): 69-72, 1998

P.175 掲載の参考文献

• 1) Murphy S, et al: Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 34: 29-39, 1997

P.192 掲載の参考文献

• 1) 蔵本 淳: 特発性血小板減少性紫斑病分科会報告. 厚生省特定疾患特発性造血障害調査研究班平成2年度研究業績報告書, p 59, 1990

• 2) George JN, et al: Idiopathic thrombocytopenic purpura;apractical guideline developed by explit methods for American Society of Hematology. Blood 88: 3, 1996

• 3) 厚生省特定疾患特発性造血障害調査研究班: 特発性血小板減少性紫斑病 診断・治療の手引き, 昭和63年度研究業績報告書, p38, 1989

P.202 掲載の参考文献

• 1) Brandt JT, et al: Criteria for the diagnosis of lupus anticoagulants : an update. Thromb Haemost 74: 11851190, 1995

• 2) Wilson WA, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42: 1309-1311, 1999
  pubmed

P.208 掲載の参考文献

• 1) 田中一郎. 吉岡 章: 症候からみた小児の診断学-紫斑, 出血傾向. 小児科診療 60 Suppl: 397-402, 1997

• 2) 吉岡 章: 血友病 最新内科学大系21;血小板・凝固・線溶異常, pp185-200, 中山書店, 東京, 1992

• 3) 田中一郎,吉岡 章: 血液疾患-state of arts;血友病. 医学のあゆみ (別冊): 415-418, 1993

• 4) 田中一郎, 吉岡 章: 血液・造血器疾患の薬物治療;血友病. 医学と薬学40: 448-453, 1998

P.214 掲載の参考文献

• 1) 田中一郎, 吉岡 章: 症候からみた小児の診断学紫斑, 出血傾向. 小児科診療 60 Suppl: 397-402, 1997

• 2) 西野正人, 吉岡 章: von Willebrand病. 小児慢性特定疾患治療マニュアル, pp435-437, 診断と治療社,東京, 1999

• 3) 西野正人: von Willebrand病の診断と治療. 日小血会誌13: 410-420, 1999

• 4) 西野正人: von Willebrand病. 血栓止血誌11: 104-112, 2000

• 5) Sadler JE: A revised classification of von Willebrand disease. Thromb Haemost 71: 520-525, 1994
  pubmed

• 6) Bergamaschini L, Mannucci PM, Federici ABら: Posttransfusion anaphylactic reaction in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor. J Lab Clin Med 125: 348-355, 1995

P.218 掲載の参考文献

• 1) Kawa K: Epstein-Barr virus-associated diseases in humans. Int J Hematol 71: 108-117, 2000
  pubmed

• 2) Kawa K, et al: Mosquito allergy and Epstein-Barr virus-associated T/NK, cell lymphoproliferative disease. Blood 98: 3137-3174, 2001